phenylalanine has been researched along with meglitinide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakkali-Nadi, A; Malaisse, WJ; Malaisse-Lagae, F | 1 |
| Brasseur, R; Lins, L; Malaisse, WJ | 1 |
| Jijakli, H; Malaisse, WJ; Ulusoy, S | 1 |
| Fuhlendorff, J; Ladrière, L; Leclercq-Meyer, V; Malaisse, WJ | 1 |
| Malaisse, WJ; Sener, A | 1 |
| Landgraf, R | 1 |
| Dornhorst, A | 1 |
| Malaisse, WJ | 1 |
| Black, C; Donnelly, P; McIntyre, L; Royle, PL; Shepherd, JP; Thomas, S | 1 |
| Gosmanov, AR; Umpierrez, GE; Westerhaus, B | 1 |
| Mita, T; Watada, H | 1 |
| Bhardwaj, A; Chen, TY; Huang, Z; Kaur, J; Knaus, EE; Narang, D; Plane, F | 1 |
| Hemmingsen, B; Metzendorf, MI; Richter, B; Sonne, DP | 1 |
6 review(s) available for phenylalanine and meglitinide
| Article | Year |
|---|---|
Meglitinide analogues in the treatment of type 2 diabetes mellitus.
Topics: Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Molecular Structure; Nateglinide; Phenylalanine; Piperidines | 2000 |
Insulinotropic meglitinide analogues.
Topics: Adult; Animals; Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Phenylalanine; Piperidines; Rats | 2001 |
Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.
Topics: Animals; Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine; Piperidines | 2003 |
Meglitinide analogues for type 2 diabetes mellitus.
Topics: Benzamides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Nateglinide; Phenylalanine; Piperidines; Randomized Controlled Trials as Topic | 2007 |
Diabetes prevention: can insulin secretagogues do the job?
Topics: Benzamides; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Disease Progression; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Nateglinide; Phenylalanine; Preventive Health Services; Sulfonylurea Compounds; Treatment Outcome | 2011 |
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Topics: Adult; Benzamides; Blood Glucose; Cardiovascular Diseases; Cyclohexanes; Diabetes Mellitus, Type 2; Fasting; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Metformin; Middle Aged; Nateglinide; Phenylalanine; Randomized Controlled Trials as Topic; Sulfonylurea Compounds | 2016 |
7 other study(ies) available for phenylalanine and meglitinide
| Article | Year |
|---|---|
Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency.
Topics: Animals; Benzamides; Carbamates; Cyclohexanes; Female; Glucose; Hypoglycemic Agents; In Vitro Techniques; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Molecular Structure; Nateglinide; Phenylalanine; Piperidines; Rats; Structure-Activity Relationship; Succinates | 1994 |
Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.
Topics: Benzamides; Carbamates; Cyclohexanes; Drug Design; Glyburide; Hypoglycemic Agents; Indoles; Isoindoles; Molecular Conformation; Nateglinide; Phenylalanine; Piperidines; Stereoisomerism; Structure-Activity Relationship; Sulfonylurea Compounds | 1995 |
Dynamics of the cationic and secretory responses to A-4166 in perifused pancreatic islets.
Topics: Animals; Benzamides; Calcium; Cyclohexanes; Female; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Nateglinide; Pancreas; Phenylalanine; Rats; Rats, Wistar; Rubidium; Time Factors | 1997 |
Stimulation of insulin and somatostatin release by two meglitinide analogs.
Topics: Animals; Benzamides; Blood Glucose; Carbamates; Cyclohexanes; Female; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Nateglinide; Perfusion; Phenylalanine; Piperidines; Rats; Rats, Wistar; Somatostatin | 1997 |
Effect of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine on nutrient catabolism in rat pancreatic islets.
Topics: Animals; Benzamides; Cyclohexanes; Female; Glucose; Hypoglycemic Agents; Islets of Langerhans; Leucine; Nateglinide; Oxidation-Reduction; Phenylalanine; Rats; Rats, Wistar | 1998 |
[Glinides].
Topics: Benzamides; Cyclohexanes; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Nateglinide; Phenylalanine | 2012 |
Synthesis and biological investigations of nitric oxide releasing nateglinide and meglitinide type II antidiabetic prodrugs: in-vivo antihyperglycemic activities and blood pressure lowering studies.
Topics: Benzamides; Blood Pressure; Cyclohexanes; Humans; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Nateglinide; Nitric Oxide; Phenylalanine; Prodrugs; Spectrometry, Mass, Electrospray Ionization | 2012 |